Clinical Trials for OriCell Therapeutics

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: OriCell Therapeutics

Clinical Trials (5)

NCT07101705
An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological Malignancies
EARLY_PHASE1Recruiting
40 participants
Started: Sep 8, 2025 · Completed: Aug 1, 2028
2 conditions2 sponsors1 location
NCT06891742
Phase I Study of OriC902 in Treatment of Advanced HCC
PHASE1Recruiting
44 participants
Started: Feb 24, 2025 · Completed: Mar 31, 2028
1 condition2 sponsors2 locations
NCT06271252
A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
PHASE1Recruiting
81 participants
Started: Apr 3, 2024 · Completed: Apr 12, 2028
14 conditions1 sponsor1 location
NCT06182696
OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMM
PHASE1/PHASE2Recruiting
83 participants
Started: Oct 26, 2023 · Completed: Aug 31, 2028
1 condition1 sponsor5 locations
NCT05652920
Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC
PHASE1/PHASE2Recruiting
105 participants
Started: Dec 15, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor7 locations